CD8A and inflammatory bowel disease: For example, it exerts beneficial anticancer effects by promoting natural killer cell activity and supporting CD8+ T cell survival [73], whereas it has detrimental effects in inflammatory bowel disease, inducing the production of other pro-inflammatory cytokines by activating macrophages [70,74,75].